Novartis Agrees To Pay Over $642M To Settle Improper Payments To Patients And Physicians Allegations
The United States Department of Justice announced on July 1, 2020 that New Jersey-based Novartis Pharmaceuticals Corporation (“Novartis”) has agreed to pay over $642 million in separate settlements resolving claims that it violated the False Claims Act (FCA). The first settlement pertain[...]
